| Product Code: ETC6346559 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Age-Related Macular Degeneration Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Age-Related Macular Degeneration Market Revenues & Volume, 2021 & 2031F |
3.3 Belgium Age-Related Macular Degeneration Market - Industry Life Cycle |
3.4 Belgium Age-Related Macular Degeneration Market - Porter's Five Forces |
3.5 Belgium Age-Related Macular Degeneration Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Belgium Age-Related Macular Degeneration Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Belgium Age-Related Macular Degeneration Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Belgium Age-Related Macular Degeneration Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing aging population in Belgium |
4.2.2 Growing prevalence of age-related macular degeneration |
4.2.3 Technological advancements in diagnosis and treatment of the disease |
4.3 Market Restraints |
4.3.1 High treatment costs associated with age-related macular degeneration |
4.3.2 Limited awareness among the general population about the disease and available treatment options |
5 Belgium Age-Related Macular Degeneration Market Trends |
6 Belgium Age-Related Macular Degeneration Market, By Types |
6.1 Belgium Age-Related Macular Degeneration Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Belgium Age-Related Macular Degeneration Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Belgium Age-Related Macular Degeneration Market Revenues & Volume, By Eylea, 2021- 2031F |
6.1.4 Belgium Age-Related Macular Degeneration Market Revenues & Volume, By Lucentis, 2021- 2031F |
6.1.5 Belgium Age-Related Macular Degeneration Market Revenues & Volume, By Beovu, 2021- 2031F |
6.1.6 Belgium Age-Related Macular Degeneration Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Belgium Age-Related Macular Degeneration Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Belgium Age-Related Macular Degeneration Market Revenues & Volume, By Dry AMD, 2021- 2031F |
6.2.3 Belgium Age-Related Macular Degeneration Market Revenues & Volume, By Wet AMD, 2021- 2031F |
6.3 Belgium Age-Related Macular Degeneration Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Belgium Age-Related Macular Degeneration Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Belgium Age-Related Macular Degeneration Market Revenues & Volume, By Specialty Pharmacy, 2021- 2031F |
6.3.4 Belgium Age-Related Macular Degeneration Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Belgium Age-Related Macular Degeneration Market Import-Export Trade Statistics |
7.1 Belgium Age-Related Macular Degeneration Market Export to Major Countries |
7.2 Belgium Age-Related Macular Degeneration Market Imports from Major Countries |
8 Belgium Age-Related Macular Degeneration Market Key Performance Indicators |
8.1 Number of patients diagnosed with age-related macular degeneration annually |
8.2 Adoption rate of advanced treatment technologies in Belgium |
8.3 Rate of reimbursement for age-related macular degeneration treatments by insurance providers |
9 Belgium Age-Related Macular Degeneration Market - Opportunity Assessment |
9.1 Belgium Age-Related Macular Degeneration Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Belgium Age-Related Macular Degeneration Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Belgium Age-Related Macular Degeneration Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Belgium Age-Related Macular Degeneration Market - Competitive Landscape |
10.1 Belgium Age-Related Macular Degeneration Market Revenue Share, By Companies, 2024 |
10.2 Belgium Age-Related Macular Degeneration Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here